Austar Lifesciences Limited (HKG:6118)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7350
+0.0050 (0.68%)
Sep 11, 2026, 9:31 AM HKT

Austar Lifesciences Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6131,5311,5001,7642,1572,015
Revenue Growth
5.39%2.02%-14.93%-18.23%7.04%55.48%
Gross Profit
292.28293.27301.22336.05488.8479.01
Operating Income
42.4443.134.77-41.21122.79116.97
Net Income
17.2733.8116.08-113.4787.46277.3
Earnings Per Share
0.030.070.03-0.220.170.54
EPS Growth
-48.92%110.25%---68.40%800.00%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Inter-Segment
-366.55-314.94-278.51-275.54-306.82-164.8
Integrated Process and Packaging Equipment & Systems
1,1171,006821.33984.85--
Consulting,digitalization and Construction
529.36509.58611.42732.65--
Life Science Equipment and Consumables
333.37329.65346.16321.78391.81428.39
Total
1,6131,5311,5001,7642,1572,015

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
209.69227.39167.81173.77148.13219.74
Total Debt
268.24343.68401.95496.2336.55155.22
Net Cash (Debt)
-58.55-116.28-234.15-322.43-188.4264.52
Net Cash Growth
------36.53%
Net Cash Per Share
-0.11-0.23-0.46-0.63-0.370.13

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
181.45132.198.81-62.65-37.93-103.45
Capital Expenditures
-44.9-23.1-20.49-69.24-117.11-100.57
Free Cash Flow
136.5410978.31-131.88-155.04-204.02
Free Cash Flow Growth
25.27%39.18%----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
18.12%19.16%20.08%19.05%22.66%23.77%
Operating Margin
2.63%2.82%2.32%-2.34%5.69%5.80%
Pretax Margin
2.20%3.14%1.41%-1.95%5.54%15.84%
Profit Margin
1.07%2.21%1.07%-6.43%4.06%13.76%
FCF Margin
8.46%7.12%5.22%-7.48%-7.19%-10.13%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
18.9011.8517.08-10.4722.71
Forward PE
-4.804.804.804.804.80
P/FCF Ratio
2.393.683.51---
PS Ratio
0.200.260.180.410.433.13